The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies-Reference-Cited by-同舟云学术

The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies

Published:2021-06 Issue:5 Volume:9 Page:581-589
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Narula Neeraj¹^ORCID,Aruljothy Achuthan¹,Wong Emily C. L.¹^ORCID,Homenauth Ravi¹,Alshahrani Abdul‐Aziz¹²,Marshall John K.¹,Reinisch Walter³

Affiliation:

1. Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute McMaster University Hamilton Ontario Canada

2. Department of Gastroenterology Najran University Najran Saudi Arabia

3. Department of Internal Medicine III Division of Gastroenterology and Hepatology Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12094

Reference26 articles.

1. Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis

2. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

3. Inflammatory bowel disease: Looking beyond the tract

4. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

5. Anemia in Children With Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment;Biomedicines;2024-08-13

3. IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or Reinduction;Journal of Clinical Medicine;2024-07-09

4. Effect of ustekinumab on extraintestinal manifestations in patients with Crohn’s disease or ulcerative colitis;Meditsinskiy sovet = Medical Council;2024-06-10

5. Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations;Journal of Crohn's and Colitis;2024-01-08